Skip to main content
Probi logo

Probi — Investor Relations & Filings

Ticker · PROB ISIN · SE0001280355 LEI · 5493004CJOCT273MU397 ST Manufacturing
Open in API
Filings indexed 410 across all filing types
Latest filing 2012-03-21 Regulatory Filings
Country SE Sweden
Listing ST PROB

About Probi

https://www.probi.com/

Probi is a global biotics company specializing in the research, development, and manufacturing of clinically documented probiotic strains. The company provides biotic solutions for dietary supplements and functional foods, targeting specific health needs across various life stages. Its portfolio addresses key areas such as digestive, immune, mental, and metabolic health, alongside specialized formulations for women, children, and healthy aging. Probi's offerings are founded on extensive scientific research and clinical studies to ensure proven efficacy in supporting human health.

Recent filings

Filing Released Lang Actions
Probi tecknar distributionsavtal med probiotisk marknadsledare i Indien
Regulatory Filings Classification · 1% confidence The document is a press release announcing a new distribution agreement between Probi and USV Limited for a probiotic product in India. This announcement details a strategic business development, specifically a partnership for market expansion and product launch. This type of announcement, which is not a standard regulatory filing like 10-K, ER, or IR, nor is it related to management changes, dividends, or shareholder votes, best fits the category for general corporate news or regulatory filings that don't fit elsewhere. Given the options, it is a significant corporate announcement. Since it is not a report itself (like 10-K or IR) and is a specific business development announcement, it is most appropriately classified as a general Regulatory Filing (RNS) as it is a public disclosure required by market rules, or potentially a general corporate announcement if a more specific category existed. However, 'RNS' serves as the best fallback for significant, non-standard disclosures. It is too specific for 'LTR' (Legal) or 'CAP' (Financing).
2012-03-21 Swedish
Gun-Britt Fransson ny Vice President Research & Development på Probi
Board/Management Information Classification · 1% confidence The document announces the appointment of a new executive, Gun-Britt Fransson, as Vice President Research & Development at Probi. This type of announcement, detailing changes in senior management or the board of directors, directly corresponds to the definition of 'Board/Management Information'. The document is short and focuses entirely on this personnel change, making 'MANG' the most appropriate classification.
2012-02-29 Swedish
Earnings Release 2011
Earnings Release Classification · 1% confidence The document text contains financial highlights, performance metrics (Nettoomsättning, Rörelseresultat, Resultat efter skatt), comparisons between Q4 2011 and Q4 2010, and full-year (Helår 2011) results. It includes a CEO commentary and detailed tables summarizing financial figures. The title 'PROB BOKS I AB LUTSKO MMUNIK É 2011' and the section 'FJÄRDE KVARTA LET 2011' strongly suggest a periodic financial report. Since it covers the fourth quarter and the full year, and is comprehensive rather than just a brief announcement, it aligns best with an Interim/Quarterly Report (IR) or potentially an Annual Report (10-K) if it were the final, audited version. Given the structure focusing on a specific quarter and year-end summary, 'Interim / Quarterly Report' (IR) is the most appropriate classification, as it details performance for a reporting period shorter than a full fiscal year (even though it covers the whole year, the focus on Q4 suggests a periodic release structure common in quarterly filings). It is not a short announcement (RPA/RNS) because the document is extensive (56,634 characters) and contains the detailed results themselves. Q4 2011
2012-01-25 Swedish
Probi ingår utvecklingsavtal med ledande globalt livsmedelsföretag
Regulatory Filings Classification · 1% confidence The document is titled 'PRESSMEDDELANDE' (Press Release) and announces a development agreement between Probi and a global food company regarding clinical development for ProbiDefendumTM, focusing on securing an EU health claim. It includes details about a future clinical study, strategic partnership terms, and contact information. Crucially, it states that the information is disclosed according to securities market laws, indicating a regulatory disclosure. However, it is not a full financial report (10-K, IR), a specific voting result (DVA), or a management/board change (MANG). It announces a significant business development/partnership, which often falls under general regulatory announcements or specific transaction categories. Since it details a strategic agreement and future clinical plans rather than a financial result (ER) or a formal transaction filing (TAR), and given its nature as a public announcement of material information, it best fits the general 'Regulatory Filings' (RNS) category, as it is a mandatory disclosure of material, non-financial news, or it could be argued as a Capital/Financing Update (CAP) if the agreement implies significant future revenue/funding, but RNS is a safer general disclosure category for press releases of this nature. Given the options, RNS is the most appropriate fallback for a material press release that doesn't fit a more specific business event category like M&A or Dividend.
2011-11-03 Swedish
Interim / Quarterly Report 2011
Interim / Quarterly Report Classification · 1% confidence The document is titled 'PROBI AB DELÅRSRAPPORT 2011' (Interim Report) and covers the period from January 1, 2011, to September 30, 2011. It contains detailed financial statements, including income statements, cash flow analysis, segment reporting, and management commentary on business performance. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2011
2011-10-19 Swedish
Major Shareholding Notification 2011
Major Shareholding Notification Classification · 1% confidence The document explicitly details a change in shareholding ('Before the transaction' vs. 'After the transaction'), specifying the number of shares and the resulting percentage of voting rights. The 'Reason for major shareholding notification' is listed as 'Sell'. This structure is characteristic of a Major Shareholding Notification, where an investor reports crossing ownership thresholds. This aligns directly with the definition for Major Shareholding Notification (MRQ). The document is short and contains specific transactional data, not a full report or an announcement about a report.
2011-09-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.